4,0
23. Sep. 2024
Aktueller Mitarbeiter, mehr als 3 Jahre
Empfehlen
CEO-Befürwortung
Geschäftsprognose
Pros
Remote work opportunities available across functions and U.S. geographies. Good basic corporate benefits. Company is growing its U.S. presence with a new manufacturing facility in New Jersey. Strong company prospects ahead from key commercialized drug products. Generally supportive, effective, and nice culture
Kontras
Uncertainties surrounding company stock and growth reflect exposure to U.S. politics regarding China. Decentralization and rapid growth have created some challenges to keeping up with effective internal infrastructures. Creating relationships across the organization can also be a challenge, reflecting a wide global geographic footprint